(Q35077240)

6 August 2017

1 reference

title

Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives (English)

1 reference

Poxviridae infectious disease

6 August 2017

main subject

1 reference

Erik De Clercq

2

0 references

Johan Neyts

object named as

Johan Neyts

series ordinal

1

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

57

1 reference

6 August 2017

issue

1-2

1 reference

6 August 2017

page(s)

25-33

1 reference

Treatment of Infections Due to Herpesvirus in Humans: A Critical Review of the State of the Art

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for the design of chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Bioterrorism. Vaccines for biodefense: a system in distress

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Topical cidofovir for severe molluscum contagiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Cidofovir in the treatment of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Broad-spectrum antiviral activity of adenosine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Antiviral activity of polyribocytidylic acid in cells primed with polyriboinosinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Smallpox vaccines. New cache eases shortage worries

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Public health. 'Destructionists' fight to keep a dream alive

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Field trials of methisazone as a prophylactic agent against smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Re-emergence of monkeypox in Africa: a review of the past six years

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Emergency response to a smallpox attack: the case for mass vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Progressive vaccinia treated with ribavirin and vaccinia immune globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Topical treatment of vaccinia virus infection with an interferon inducer in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Branched-chain sugar nucleosides. 3. 3'-C-methyladenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

New neplanocin analogues. 7. Synthesis and antiviral activity of 2-halo derivatives of neplanocin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Synthesis and antiviral properties of (+/-)-5'-noraristeromycin and related purine carbocyclic nucleosides. A new lead for anti-human cytomegalovirus agent design

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Antiviral enantiomeric preference for 5'-noraristeromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

An epimer of 5'-noraristeromycin and its antiviral properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Rifampicin inhibits the growth of some mammalian viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

Branched-chain sugar nucleosides. V. Synthesis and antiviral properties of several branched-chain sugar nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900197-3

7 January 2021

10.1016/S0166-3542(02)00197-3

Identifiers

DOI

1 reference

6 August 2017

1 reference